Drugs / Shuganhuazhuo Formula
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07691645 | Sep 2026 → Aug 2029 expected | hepatocellular carcinoma | Xiang-Qian | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shuganhuazhuo Formula | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07691645 ↗ |
| Known as | SHF | “Shuganhuazhuo Formula(SHF) is a Chinese herbal medicine used to treat advanced HCC with syndrome of Damp-Heat and Blood stasis.” NCT07691645 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Shuganhuazhuo Formula(SHF) is a Chinese herbal medicine used to treat advanced HCC with syndrome of Damp-Heat and Blood stasis.” NCT07691645 ↗ |
| Route | Oral | “taken orally half an hour after breakfast and dinner” NCT07691645 ↗ |